Top

Published in:

01-04-2019 | Editorial

Ischemia and inflammation on chronic kidney disease

Author: Nagara Tamaki, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 2/2019

Excerpt

Compared with the general population, dialysis patients have a greater incidence of cardiovascular death, mainly due to the high prevalence of either underlying coronary artery disease before starting hemodialysis or cardiovascular risk factors in those with end stage renal disease.1‐4 Chronic kidney disease (CKD) in general, has a higher incidence of coronary artery disease. The adjusted hazard ratio for death and cardiovascular events increases inversely with estimated glomerular filtration rates (eGFR).5,6 …

Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9(Suppl 12):S16-23.PubMed

Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross-sectional study. J Am Soc Nephrol 2001;12:1516-23.PubMed

Foley RN, Parfrey PS. Cardiac disease in chronic uremia: Clinical outcome and risk factors. Adv Ren Replace Ther 1997;4:234-48.CrossRefPubMed

Fung F, Sherrard DJ, Gillen DL, et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 2002;40:307-14.CrossRefPubMed

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risk of death, cardio vascular events, and hospitalization. N Engl J Med 2004;351:1296-305.CrossRefPubMed

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular diseases: A statement from the American Heart Association Councils on Kidney in cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.CrossRefPubMed

Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: A randomized controlled trial. Am J Kidney Dis 2009;54:602-09.CrossRefPubMed

Hatta T, Nishimura S, Nakajima T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Mol Imaging 2009;36:1835-41.CrossRef

Nakajima K, Nishimura T. Inter-institution preference-based variability of ejection fraction and volumes using quantitative gated SPECT with 99mTc-tetrofosmin: A multicentre study involving 106 hospitals. Eur J Nucl Med Mol Imaging 2006;33:127-33.CrossRefPubMed

10.

Momose M, Babazono T, Kondo C, Kobayashi H, Nakajima T, Kusakabe K. Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Mol Imaging 2009;36:1315-21.CrossRef

11.

Hase H, Joki N, Ishikawa H, Fukuda H, Imamura Y, Saijyo T, et al. Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19:1161-67.CrossRefPubMed

12.

Hakeem A, Bhatti S, Dille KS, Cook JR, Samad Z, Roth-Cline MD, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008;118:2540-49.CrossRefPubMed

13.

Nakajima K, Matsuo S, Okuyama C, Hatta T, Tsukamoto K, Nishimura S, et al. Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease. Circ J 2012;76:168-75.CrossRefPubMed

14.

Doukky R, Fughhi I, Campagnoli T, Wassouf M, Ali A. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol 2017;24:112-18.CrossRefPubMed

15.

Bhatti S, Hakeem A, Dhanalakota S, Palani G, Husain Z, Jacobsen G, Ananthasubramaniam K. Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction. Eur Heart J Cardiovasc Imaging 2014;15:933-40.CrossRefPubMed

16.

ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease Circulation 2012;126:e354-e471.

Title: Ischemia and inflammation on chronic kidney disease
Author: Nagara Tamaki, MD, PhD
Publication date: 01-04-2019
Publisher: Springer International Publishing
Published in: Journal of Nuclear Cardiology / Issue 2/2019
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-017-0997-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Ischemia and inflammation on chronic kidney disease

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2019

Myocardial perfusion scintigraphy during chest pain: An atypical presentation of takotsubo cardiomyopathy?

What is this image? 2019: Image 5 result

18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: Female sex and history of atrioventricular block increase the prevalence of positive PET findings

Interactions between myocardial sympathetic denervation and left ventricular mechanical dyssynchrony: A CZT analysis

Nuclear imaging of cardiac amyloidosis

How to achieve patient-centered testing: role of the protocol nurse

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page